- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04014725
Validation of the Utility of Myopia Intelligent Diagnostic System
July 8, 2019 updated by: Haotian Lin, Sun Yat-sen University
Validation of the Utility of Myopia Intelligent Diagnostic System: A Clinical Trial
The screening of myopia via artificial intelligence represents an challenge in computational medicine.
Here, the investigators use "deep learning" to create an automatic diagnostic system for myopia screening using ocular appearance images.
The investigator also use this system and conduct clinical trial to validate its performance.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
6 years to 18 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Student aged 6-18
Exclusion Criteria:
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Eligible patients for AI test
|
An artificial intelligence to make diagnosis of myopia using ocular appearance images
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The AUC of the Myopia Intelligent Diagnostic System
Time Frame: up to 3 month
|
up to 3 month
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The sensitivity of the Myopia Intelligent Diagnostic System
Time Frame: up to 3 month
|
up to 3 month
|
|
The specificity of the Myopia Intelligent Diagnostic System
Time Frame: up to 3 month
|
up to 3 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
July 10, 2019
Primary Completion (Anticipated)
August 1, 2019
Study Completion (Anticipated)
August 1, 2019
Study Registration Dates
First Submitted
July 1, 2019
First Submitted That Met QC Criteria
July 8, 2019
First Posted (Actual)
July 10, 2019
Study Record Updates
Last Update Posted (Actual)
July 10, 2019
Last Update Submitted That Met QC Criteria
July 8, 2019
Last Verified
July 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CCPMOH2019-China-2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myopia
-
Tianjin Medical University Eye HospitalNot yet recruitingProgressive Myopia | Pediatric Myopia | Orthokeratology-related Myopia Progression
-
Shanghai General Hospital, Shanghai Jiao Tong University...Not yet recruitingMyopia | Myopia, ProgressiveChina
-
SightGlass Vision, Inc.Recruiting
-
University of FaisalabadCompletedRefractive Errors | Myopia | Progressive MyopiaPakistan
-
SightGlass Vision, Inc.RecruitingMyopia | Myopia Progression | Juvenile MyopiaUnited States
-
Shanghai Eye Disease Prevention and Treatment CenterEnrolling by invitationMyopia, Child Myopia ProgressionChina
-
He Eye HospitalNot yet recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityActive, not recruiting
-
University Eye Hospital, FreiburgActive, not recruiting
-
University of BradfordUniversity of Huddersfield; CooperVision International Limited (CVIL)Enrolling by invitationMyopia, ProgressiveUnited Kingdom
Clinical Trials on Myopia Intelligent Diagnostic System
-
Fuzhou General HospitalNot yet recruiting
-
Fuzhou General HospitalNot yet recruitingLung Cancer in Normal and Malignant TumorsChina
-
RenJi HospitalChanghai Hospital; Peking University People's Hospital; Shanghai Zhongshan Hospital and other collaboratorsRecruiting
-
Xuanwu Hospital, BeijingThe First Hospital of Jilin UniversityNot yet recruitingOrthostatic HypotensionChina
-
Fuzhou General HospitalNot yet recruitingLung Cancer, Non-Small Cell | Lung Cancer Small Cell Lung Cancer (SCLC)
-
Fuzhou General HospitalNot yet recruiting
-
Sun Yat-sen UniversityCompletedArtificial Intelligence | OphthalmopathyChina
-
Zan WangRecruiting
-
Pixium Vision SACompletedRetinitis Pigmentosa | Choroideremia | Cone Rod DystrophyAustria, Spain, United Kingdom, France, Germany
-
Pixium Vision SACompletedRetinitis Pigmentosa | Choroideremia | Cone Rod DystrophyAustria, France, Germany